Terms: = Uterine cancer AND KAT6A
4 results:
1. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
[TBL] [Abstract] [Full Text] [Related]
2. Expression of epigenetic pathway related genes in association with PD-L1, ER/PgR and MLH1 in endometrial carcinoma.
Saglam O; Cao B; Wang X; Toruner GA; Conejo-Garcia JR
PLoS One; 2022; 17(2):e0264014. PubMed ID: 35226658
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-related Myeloid Leukemia With the Translocation t(8;19)(p11;q13) Leading to a
Panagopoulos I; Andersen K; Ramslien LF; Ikonomou IM; Micci F; Heim S
Anticancer Res; 2021 Apr; 41(4):1753-1760. PubMed ID: 33813379
[TBL] [Abstract] [Full Text] [Related]
4. kat6a amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract] [Full Text] [Related]
